BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28539088)

  • 1. Prescription Patterns and Disease Control in Type 2 Diabetes Mellitus Patients in Nursing Home and Home Care Settings: A Retrospective Analysis in Germany.
    Kostev K; Rockel T; Jacob L
    J Diabetes Sci Technol; 2018 Jan; 12(1):136-139. PubMed ID: 28539088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
    Neumark AS; Brudin L; Neumark T
    Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription patterns and drug costs in German patients with dementia in nursing homes and home-care settings
.
    Jacob L; Bohlken J; Kostev K
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):9-15. PubMed ID: 27879194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses.
    Rathmann W; Pscherer S; Konrad M; Kostev K
    Prim Care Diabetes; 2016 Feb; 10(1):36-40. PubMed ID: 25937183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010).
    Kostev K; Rathmann W
    Prim Care Diabetes; 2013 Oct; 7(3):229-33. PubMed ID: 23608219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Patterns and the Cost of Antihyperglycemic Drugs in Patients With Type 2 Diabetes Mellitus in Germany.
    Jacob L; von Vultee C; Kostev K
    J Diabetes Sci Technol; 2017 Jan; 11(1):123-127. PubMed ID: 27402240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
    Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
    Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
    Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to Insulin Initiation in Type 2 Diabetes Patients in 2010/2011 and 2016/2017 in Germany.
    Kostev K; Gölz S; Scholz BM; Kaiser M; Pscherer S
    J Diabetes Sci Technol; 2019 Nov; 13(6):1129-1134. PubMed ID: 30862186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000-2019.
    Lee KA; Jin HY; Kim YJ; Im YJ; Kim EY; Park TS
    J Korean Med Sci; 2021 Sep; 36(36):e230. PubMed ID: 34519186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.
    Burgmann K; Fatio S; Jordi B; Rutishauser J
    Swiss Med Wkly; 2013; 143():w13871. PubMed ID: 24163110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of insulin as a first-line therapy and associated factors in people with type 2 diabetes in German primary care practices.
    van den Boom L; Kaiser M; Kostev K
    Diabet Med; 2020 Aug; 37(8):1333-1339. PubMed ID: 32506471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin prescription patterns among US adolescents aged 10-19 years: 2009-2013.
    Wang T; McNeill AM; Chen Y; Senderak M; Shankar RR
    J Clin Pharm Ther; 2016 Apr; 41(2):229-36. PubMed ID: 26960965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.
    Umpierrez GE; Cardona S; Chachkhiani D; Fayfman M; Saiyed S; Wang H; Vellanki P; Haw JS; Olson DE; Pasquel FJ; Johnson TM
    J Am Med Dir Assoc; 2018 May; 19(5):399-404.e3. PubMed ID: 29289540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.